Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 51407-948

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 51407-948). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-948-30lb (Buprenorphine and Naloxone 2mg 0.5mg -rev 0426.jpg)

Label for Buprenorphine and Naloxone sublingual tablets USP with a strength of 2 mg/0.5 mg. The label indicates a 30-tablet bottle distributed by Golden State Medical Supply, Inc., with warnings about accidental ingestion by children and storage instructions. The label includes the NDC 51407-948-30 and notes prescription use only.*

FDA Label Image

51407-949-30lb (Buprenorphine and Naloxone 8mg 2mg)

Label for buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablets, USP, strength 8 mg/2 mg. The label includes warnings for accidental ingestion by children and dosing instructions. Marketed by Golden State Medical Supply, Inc., the package contains 30 tablets for prescription use only.*

FDA Label Image

Buprenorphine-chem-structure.jpg (Image 02)

Chemical structure of buprenorphine hydrochloride, showing the molecular arrangement of the active ingredient in the product buprenorphine hydrochloride and naloxone hydrochloride dihydrate.*

FDA Label Image

Bupr-naloxone-ifu-mouth-image (Image 03)

An instructional illustration showing a hand placing a tablet under the tongue inside an open mouth. The image depicts the sublingual administration of a tablet.*

FDA Label Image

Naloxone-chem-structure.jpg (Image 04)

Chemical structure of buprenorphine hydrochloride and naloxone hydrochloride dihydrate, showing the molecular framework with multiple rings, functional groups, and hydration elements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.